SpineSeal Spine Sealant
Pramand, LLC · Decision date Feb 14, 2025
What did the FDA approve?
FDA records P240027 as an original PMA application. The recorded decision is approval, dated Feb 14, 2025.
FDA approval order statement
The SpineSeal Spine Sealant is indicated for use as an adjunct to sutured dural repair during spinal surgery to provide watertight closure.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Neurology
- Decision date
- Feb 14, 2025
Regulatory record facts
- Identifier
- P240027
- Regulatory pathway
- Premarket approval application
- Applicant
- Pramand, LLC
- Product code
- NQR
- Decision code
- APPR
- Decision date
- Feb 14, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sealant, dural.
- Applicant
- Pramand, LLC
- Product code
- NQR
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P240027 received
Application receipt date recorded by FDA.
P240027 · FDA decision
APPR
P240027/S007 · Related supplement
SpineSeal Spine Sealant
Timeline entries are records held by MedtechLedger for P240027. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240027
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
SpineSeal Spine SealantP240027/S007 | Pramand, LLC | PMA supplement | Sep 11, 2026 | FDA |
Explore the linked device profile
Other records with product code NQR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CraniSeal Dural SealantP220014/S013 | Pramand, LLC | PMA supplement | Oct 1, 2026 | FDA |
CraniSeal Dural SealantP220014 | Pramand, LLC | PMA approval | Jul 6, 2023 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Pramand, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 201 Burlington Rd., Suite 210, Bedford, MA, 02420
Sources and methodology
- Original FDA record: P240027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
